Dutch Medtech Company ViCentra Secures €72M In Series D Round

Led by new investor Innovation Industries, with support from Partners in Equity, Invest-NL, EQT Life Sciences, and Health Innovations, the funding will scale manufacturing, launch the Kaleido 2 patch pump in Europe, and pave the way for U.S. market entry.

"ViCentra is redefining insulin pump therapy with a platform that truly centers the user experience – combining clinical performance with design simplicity and wearability," commented Caaj Greebe, Partner at Innovation Industries.

Read Also - Seaya Acquires Spain-based Adsmurai

"At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry."

Kaleido is the smallest, lightest and most precise insulin patch pump in its class, designed as a discreet, intuitive and personalized lifestyle device. Featuring premium materials and customizable aluminum shells, it integrates Diabeloop’s self-learning insulin algorithm and Dexcom CGM compatibility. Strong early uptake in Germany, France, and the Netherlands positions ViCentra for rapid growth and improved diabetes care worldwide.

"Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honors those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve," said Tom Arnold, Chief Executive Officer at ViCentra.

About ViCentra

ViCentra is dedicated to making life with diabetes easier and better through thoughtful innovation and elegant design. The company creates the Kaleido insulin patch pump a flexible, discreet, and stylish alternative to traditional pumps. Based in Utrecht, Netherlands, ViCentra is growing across Europe and preparing to enter the U.S., backed by investors like Innovation Industries, Partners in Equity, Invest-NL, EQT Life Sciences, Health Innovations, and INKEF.